Role of interleukin-2 in the immune response
Endogenous interleukin-2 plays a key role in the activation of cell-mediated immunity. Its effects include:
- Stimulation of proliferation: IL-2 binds to its specific receptors on T-lymphocytes, promoting their transition from the resting phase ($G_1$) to the DNA synthesis phase ($S$-phase), which leads to active cell division.
- Activation of cell-mediated immunity: Under the influence of IL-2, type 1 T-helper cells are stimulated. They begin to secrete interferon-gamma (IFN-$\gamma$), which in turn activates T-killer cells and macrophages necessary for the destruction of damaged and tumor cells.
- Development of the humoral response: IL-2 also affects type 2 T-helper cells. These cells produce interleukin-4 (IL-4), a mediator that triggers the proliferation of B-lymphocytes, ultimately leading to the production of antibodies (e.g., IgE).
Mechanism of action of aldesleukin
Aldesleukin, being an analog of natural IL-2, reproduces its pharmacodynamic effects:
- Binds to specific IL-2 receptors on the surface of immune cells.
- Stimulates the differentiation and active division of T-lymphocytes, as well as other cell populations dependent on interleukin-2.
- Significantly increases the cytotoxic activity of T-lymphocytes and natural killer (NK) cells against tumor cells.
- Induces the release of a cascade of other important cytokines, including IFN-$\gamma$, tumor necrosis factor (TNF), and interleukin-1 (IL-1).
Medical applications
Due to its pronounced ability to activate cytotoxic cells of the immune system, aldesleukin has found application in oncology. Its main indication is the treatment of renal cell carcinoma. The drug mobilizes the body's own defenses to combat the malignant neoplasm by enhancing the recognition and destruction of tumor cells.
Class and exam questions
What is aldesleukin and which group does it belong to?
This is a recombinant analogue of endogenous interleukin-2. It belongs to the group of cytokines used to regulate the immune response.
What is the main indication for prescribing aldesleukin?
The primary indication for the use of this drug is renal cell carcinoma.
Which cells does aldesleukin activate to fight the tumor?
The drug increases the cytotoxicity of T-lymphocytes and natural killer (NK) cells.
The production of which cytokines does aldesleukin induce?
It stimulates the production of interferon-gamma (IFN-γ), tumor necrosis factor (TNF), and interleukin-1 (IL-1).
What else to study on this topic
- The role of other interleukins in immunity (IL-3, IL-4, IL-5)
- Cytokine antagonists (anakinra, etanercept, infliximab)
- Colony-stimulating factors
- Mechanism of inflammation and the role of IL-1β in gout
- Steroidal anti-inflammatory drugs and immunosuppression
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Aldesleukin" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the «Drugs and Prescriptions» section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.